MAP3K6
Basic information
Region (hg38): 1:27355184-27366961
Links
Phenotypes
GenCC
Source:
- gastric cancer (Limited), mode of inheritance: Unknown
- hereditary diffuse gastric adenocarcinoma (Supportive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Familial gastric cancer | AD | Oncologic | Awareness of the risk of diffuse gastric cancer may allow preventive measures and early diagnosis and treatment | Oncologic | 25340522 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MAP3K6 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 11 | |||||
missense | 83 | 10 | 99 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 1 | 1 | ||||
non coding | 3 | |||||
Total | 0 | 1 | 84 | 16 | 16 |
Variants in MAP3K6
This is a list of pathogenic ClinVar variants found in the MAP3K6 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-27355401-G-C | not specified | Uncertain significance (Apr 07, 2022) | ||
1-27355435-A-T | not specified | Uncertain significance (Aug 28, 2024) | ||
1-27355452-C-T | not specified | Uncertain significance (Jul 02, 2024) | ||
1-27355675-C-T | not specified | Uncertain significance (Mar 14, 2023) | ||
1-27355675-CG-C | Uncertain significance (Nov 01, 2023) | |||
1-27355678-G-A | not specified | Uncertain significance (Oct 29, 2021) | ||
1-27355706-A-C | not specified | Uncertain significance (Dec 11, 2023) | ||
1-27355710-G-A | MAP3K6-related disorder | Benign (Dec 31, 2019) | ||
1-27356019-G-A | MAP3K6-related disorder | Likely benign (Nov 12, 2019) | ||
1-27356039-C-G | MAP3K6-related disorder | Benign (Apr 24, 2019) | ||
1-27356046-C-G | not specified | Uncertain significance (Sep 14, 2022) | ||
1-27356082-G-C | not specified | Uncertain significance (Sep 14, 2021) | ||
1-27356402-G-A | not specified | Uncertain significance (Oct 05, 2023) | ||
1-27356436-G-C | not specified | Uncertain significance (Nov 15, 2023) | ||
1-27356471-C-T | not specified | Uncertain significance (May 05, 2023) | ||
1-27356495-C-T | MAP3K6-related disorder | Likely benign (Mar 01, 2024) | ||
1-27356496-G-A | not specified | Uncertain significance (Sep 04, 2024) | ||
1-27356633-G-A | not specified | Uncertain significance (Mar 08, 2024) | ||
1-27356689-T-C | Benign (Apr 10, 2018) | |||
1-27356725-G-A | not specified | Likely benign (Mar 19, 2024) | ||
1-27356738-CCTT-C | MAP3K6-related disorder | Benign (Nov 01, 2024) | ||
1-27357019-C-A | Likely benign (Apr 10, 2018) | |||
1-27357088-C-G | not specified | Uncertain significance (Jul 14, 2021) | ||
1-27357124-G-A | MAP3K6-related disorder | Benign (Dec 23, 2019) | ||
1-27357468-C-T | not specified | Uncertain significance (Oct 29, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MAP3K6 | protein_coding | protein_coding | ENST00000493901 | 29 | 11709 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.05e-16 | 0.998 | 124657 | 4 | 1087 | 125748 | 0.00435 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.24 | 651 | 746 | 0.872 | 0.0000478 | 8159 |
Missense in Polyphen | 189 | 237.01 | 0.79743 | 2589 | ||
Synonymous | 1.99 | 271 | 316 | 0.857 | 0.0000196 | 2765 |
Loss of Function | 3.05 | 36 | 61.9 | 0.581 | 0.00000299 | 705 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00543 | 0.00539 |
Ashkenazi Jewish | 0.00282 | 0.00268 |
East Asian | 0.00132 | 0.00131 |
Finnish | 0.0104 | 0.0102 |
European (Non-Finnish) | 0.00506 | 0.00485 |
Middle Eastern | 0.00132 | 0.00131 |
South Asian | 0.00266 | 0.00255 |
Other | 0.00421 | 0.00408 |
dbNSFP
Source:
- Function
- FUNCTION: Component of a protein kinase signal transduction cascade. Activates the JNK, but not ERK or p38 kinase pathways. {ECO:0000269|PubMed:17210579, ECO:0000269|PubMed:9875215}.;
- Pathway
- MAPK signaling pathway - Homo sapiens (human);EGF-Core;MAPK Signaling Pathway;Angiopoietin Like Protein 8 Regulatory Pathway;Insulin Signaling;p38 MAPK signaling pathway
(Consensus)
Recessive Scores
- pRec
- 0.108
Intolerance Scores
- loftool
- 0.849
- rvis_EVS
- 0.37
- rvis_percentile_EVS
- 74.78
Haploinsufficiency Scores
- pHI
- 0.146
- hipred
- Y
- hipred_score
- 0.533
- ghis
- 0.510
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.976
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Map3k6
- Phenotype
- neoplasm; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); cellular phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- activation of MAPKK activity;protein phosphorylation;signal transduction;activation of JUN kinase activity
- Cellular component
- Molecular function
- magnesium ion binding;protein kinase activity;MAP kinase kinase kinase activity;ATP binding